Camden, NJ - When Sandy Stewart enrolled at Rutgers University–Camden, he was a first-generation college student who was unsure of his career path. After earning his bachelor’s (1981) and master’s (1987) degrees in biology from Rutgers–Camden, Stewart launched a highly successful career in the biotechnology industry.
Stewart credits Rutgers–Camden for an education that prepared him for his first biotech job at Ciba-Geigy/Novartis. At the time, says Stewart, as many as half the scientists hired by the company were international. It was an intimidating environment, but he was able to compete with some of the world’s best scientists “because I received such a tremendous education at Rutgers–Camden.”
Stewart went on to found or co-found several biotechnology companies, including Paradigm Genetics (now Cogenics Icoria Inc.) and Immunovation. These companies spanned functional genomics, proteomics, and metabolomics into drug development. He chairs the Rutgers University Board of Governors and is a member of the Rutgers University–Camden Board of Directors.
In recognition of Rutgers’ transformative role in his life, Stewart has made a $2.5 million bequest gift commitment to create the Sandy J. Stewart Endowed Equipment and Instruments Fund at Rutgers University–Camden. This gift will provide Rutgers–Camden students and faculty with cutting-edge instrumentation often found in core laboratories, such as mass spectrometers, flow cytometers and gene sequencers.
Through this endowment, students will have the ability to utilize equipment and instruments essential for conducting the highest level of research. The multimillion-dollar gift will enable Rutgers–Camden to expand its leadership in such areas as biology, chemistry, physics, and computational biology, a developing field that applies computational modeling to the biosciences.
Stewart was one of the first in the world to greatly advance the technology of biochemical profiling, now known as metabolomics, at Paradigm Genetics and recently continued his work at Metabolon, Inc. He has earned many awards, published numerous papers, and holds several biotechnology patents. He has worked with the American Red Cross and the United Nations on HIV research and with Prionics AG on research related to bovine spongiform encephalitis, more commonly known as “mad cow disease.”
“This gift by Sandy Stewart truly is visionary in its potential impact,” says Rutgers University–Camden Chancellor Phoebe A. Haddon. “Through the generous support of Mr. Stewart, Rutgers–Camden will extend its ability to provide students with unparalleled access to the very best resources and learning experiences in the sciences, while also contributing greatly to the research that will lead to innovations in the biosciences and technology for generations to come.
“His bequest represents a profound investment in Rutgers University–Camden’s preeminence as a global center for innovation and research in the biosciences,” continues Haddon. “It also is yet another indicator of Camden’s growing reputation as a knowledge hub for science and health care.”
Stewart’s commitment to expanding opportunities for student success at Rutgers University–Camden is long-standing and includes a previous gift that established the Sandy J. Stewart Undergraduate Research Fund, which provides awards to three biology or chemistry students who participate in original research with their faculty mentors and who are not on a pre-med track.
Formerly of Point Pleasant, N.J., Stewart now lives in New Hill, N.C.
Stewart went on to found or co-found several biotechnology companies, including Paradigm Genetics (now Cogenics Icoria Inc.) and Immunovation. These companies spanned functional genomics, proteomics, and metabolomics into drug development. He chairs the Rutgers University Board of Governors and is a member of the Rutgers University–Camden Board of Directors.
In recognition of Rutgers’ transformative role in his life, Stewart has made a $2.5 million bequest gift commitment to create the Sandy J. Stewart Endowed Equipment and Instruments Fund at Rutgers University–Camden. This gift will provide Rutgers–Camden students and faculty with cutting-edge instrumentation often found in core laboratories, such as mass spectrometers, flow cytometers and gene sequencers.
Through this endowment, students will have the ability to utilize equipment and instruments essential for conducting the highest level of research. The multimillion-dollar gift will enable Rutgers–Camden to expand its leadership in such areas as biology, chemistry, physics, and computational biology, a developing field that applies computational modeling to the biosciences.
Stewart was one of the first in the world to greatly advance the technology of biochemical profiling, now known as metabolomics, at Paradigm Genetics and recently continued his work at Metabolon, Inc. He has earned many awards, published numerous papers, and holds several biotechnology patents. He has worked with the American Red Cross and the United Nations on HIV research and with Prionics AG on research related to bovine spongiform encephalitis, more commonly known as “mad cow disease.”
“This gift by Sandy Stewart truly is visionary in its potential impact,” says Rutgers University–Camden Chancellor Phoebe A. Haddon. “Through the generous support of Mr. Stewart, Rutgers–Camden will extend its ability to provide students with unparalleled access to the very best resources and learning experiences in the sciences, while also contributing greatly to the research that will lead to innovations in the biosciences and technology for generations to come.
“His bequest represents a profound investment in Rutgers University–Camden’s preeminence as a global center for innovation and research in the biosciences,” continues Haddon. “It also is yet another indicator of Camden’s growing reputation as a knowledge hub for science and health care.”
Stewart’s commitment to expanding opportunities for student success at Rutgers University–Camden is long-standing and includes a previous gift that established the Sandy J. Stewart Undergraduate Research Fund, which provides awards to three biology or chemistry students who participate in original research with their faculty mentors and who are not on a pre-med track.
Formerly of Point Pleasant, N.J., Stewart now lives in New Hill, N.C.
